Literature DB >> 30107991

Rabies vaccines: WHO position paper, April 2018 - Recommendations.

.   

Abstract

This article presented the World Health Organization's (WHO) recommendations on the use of Rabies vaccines excerpted from the Rabies vaccines: WHO position paper - April 2018 published in the Weekly Epidemiological Record [1] This position paper replaces the 2010 WHO position paper on rabies vaccines [2]. It presents new evidence in the field of rabies and the use of rabies vaccines, focussing on programmatic feasibility, simplification of vaccination schedules and improved cost-effectiveness. The recommendations concern the 2 main immunization strategies, namely vaccination for post-exposure prophylaxis and vaccination for pre-exposure prophylaxis. In the context of post-exposure prophylaxis, recommendations are also provided on the use of rabies immunoglobulins. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation tables. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of cholera vaccines were discussed by the Strategic Advisory Group of Experts (SAGE) in October 2017; evidence presented at these meetings can be accessed at: http://www.who.int/immunization/sage/meetings/2017/october/presentations_background_docs/en/.
Copyright © 2018 World Health Organization. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Immunoglobulins; Position paper; Rabies; Recommendations; Vaccines; WHO

Mesh:

Substances:

Year:  2018        PMID: 30107991     DOI: 10.1016/j.vaccine.2018.06.061

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  44 in total

1.  Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor.

Authors:  Venice Du Pont; Christoph Wirblich; Jeong-Joong Yoon; Robert M Cox; Matthias J Schnell; Richard K Plemper
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Healthcare demand in response to rabies elimination campaigns in Latin America.

Authors:  Jonathan Yoder; Elisabeth Younce; Felix Lankester; Guy H Palmer
Journal:  PLoS Negl Trop Dis       Date:  2019-09-26

Review 3.  [What is verified for travel vaccinations?]

Authors:  Tomas Jelinek
Journal:  Internist (Berl)       Date:  2018-12       Impact factor: 0.743

4.  Long-term immunity and the effect of one or two booster doses with a lyophilized human rabies vaccine (human diploid cells) at 10 years post primary vaccination in China.

Authors:  Jialei Hu; Shiyuan Wang; Rong Zhou; Hui Liu; Xiaohong Gan; Mingwei Wei; Fengcai Zhu; Fanyue Meng; Wenli Hou
Journal:  Hum Vaccin Immunother       Date:  2021-05-04       Impact factor: 3.452

5.  Research trends in rabies vaccine in the last three decades: a bibliometric analysis of global perspective.

Authors:  Tauseef Ahmad; Muhammad Khan; Manal Abdulaziz Murad; Mukhtiar Baig; Bibi Nazia Murtaza; Muhammad Mumtaz Khan; Harapan Harapan; Jin Hui
Journal:  Hum Vaccin Immunother       Date:  2021-05-04       Impact factor: 3.452

6.  An Evaluation of the Rabies Surveillance in Southern Vietnam.

Authors:  Quang Duy Pham; Lan Trong Phan; Thuy Phuong Thi Nguyen; Quan Minh Ngoc Doan; Hai Duc Nguyen; Quang Chan Luong; Thuong Vu Nguyen
Journal:  Front Public Health       Date:  2021-04-29

7.  The crux of Pakistan's prolonged rabies vaccine shortage: A rising mortal threat in the COVID-19 pandemic.

Authors:  Adeel Siddiqui; Ali Ahmed; Maria Tanveer; Asma Arshad
Journal:  J Med Virol       Date:  2021-04-23       Impact factor: 20.693

8.  Health problems in travellers to Nepal visiting CIWEC clinic in Kathmandu - A GeoSentinel analysis.

Authors:  Prativa Pandey; Keun Lee; Bhawana Amatya; Kristina M Angelo; David R Shlim; Holly Murphy
Journal:  Travel Med Infect Dis       Date:  2021-02-24       Impact factor: 20.441

9.  Travelers' vaccines and their adverse events in Nara, Japan.

Authors:  Taku Ogawa; Nobuyasu Hirai; Natsuko Imakita; Hiroyuki Fujikura; Akihiro Kajita; Yuichiro Imai; Tomoko Onishi; Masahiro Takeyama; Kei Kasahara
Journal:  Open Med (Wars)       Date:  2021-06-30

10.  Assessing clinicians' Post-Exposure Prophylaxis recommendations for rabies virus exposures in Hunan Province, China.

Authors:  Yu Li; Jeanette J Rainey; Hao Yang; Cuc H Tran; Yang Huai; Rongqiang Liu; Hongwei Zhu; Zhengliang Wang; Di Mu; Wenwu Yin; Chun Guo; Miriam Shiferaw; Qiulan Chen; Shixiong Hu; Zhongjie Li
Journal:  PLoS Negl Trop Dis       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.